Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience

57 patients undergoing transcatheter aortic valve replacement, mean age 80.8±7.3 years, STS predicted risk of mortality 7.7±5.7%, representing the first-in-human and early Canadian experience.

Transcatheter aortic valve replacement (TAVR) with the self-expanding and repositionable Portico valve

Short- and medium-term outcomes (30 days and one year) including survival, stroke, pacemaker requirement, and echocardiographic findingshard clinical